Hynix's Nasdaq Debut Just Reshapes U.S. Tech Listings
Hynix’s move onto the Nasdaq marks a watershed moment for foreign listings in the U.S. tech space. This article break...
Determine which funds deliver the best annual risk-adjusted returns and how they stack up. Compare contenders to pick winners.
28,456 articlesHynix’s move onto the Nasdaq marks a watershed moment for foreign listings in the U.S. tech space. This article break...
A major institution disclosed a new roughly $5 million stake in Central Bancompany, helping fuel a 20% gain since its...
A federal judge dismissed a lawsuit challenging Buffalo Wild Wings' boneless wings naming, clearing the way for the c...
AI-driven data centers are reshaping memory supply. This article breaks down what data centers will consume for memor...
Regencell Bioscience sits in the high-risk, high-reward world of early-stage biotech. Before you consider investing, ...
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
One mega-cap could re-enter the elite $4 trillion club, powered by AI, cloud momentum, and strong cash flow. This pie...
Northeast metros are clearing supply faster than many Sun Belt peers, boosting seller leverage as spring demand retur...
Investors awakened to a rough start for cruise stocks as Norwegian Cruise Line Holdings shares slid. This piece break...
A major stake sale in Albertsons by a large hedge fund sparks questions about what insiders know and how it affects t...
When MoonLake Immunotherapeutics announced a larger-than-expected secondary offering, the stock wilted. This guide br...
Ethereum steadies around the 1.85K mark as traders weigh a breakout against rising moving averages and a cautious glo...